follow us on twitter: @GoAfricaNetwork 9:45 a.m. EST March 4, 2015 Drug companies who sell testosterone supplements will be required to warn patients that the products may increase the risk for heart attacks and strokes, the Food and Drug Administration announced Tuesday. The agency will require manufacturers of testosterone therapy, available by prescription, to include […]
FDA warns that testosterone increases heart risks Read More »
follow us on twitter: @ GoAfricaNetwork The Need to Fast-Track Promising Vaccines Ebola virus is among the most deadly pathogens, with case fatality rates of up to 90%.1 Ebola virus is categorized as a tier 1 pathogen by the US government because of its potential for deliberate misuse with significant potential for mass casualties. The
Emergency Treatment for Exposure to Ebola Virus Read More »
Follow us on Twitter: @GoAfricaNetwork Dr. Marie Goreti Harakeye, Head of HIV/AIDS, TB & OID Division Under the AU Department of Social Affairs The African Union (AU) is planning to establish a pan-African Centre for Disease Control and Prevention (African CDC) by mid-2015. First proposed by Ethiopia and approved by the AU Commission in 2013
Ethiopia: AU to Set Up an African CDC Read More »
Follow us on Twitter: @GoAfricaNetwork A cheap and simple way to obtain the main type of disease-supressing antibody in human blood could help save the lives of patients in the developing world with malfunctioning immune systems. The method of collecting immunoglobulin G (IgG) may enable more patients with primary immunodeficiencies (PID) to get the regular
Africa: Lab-Free Immune Therapy Developed Read More »
Follow us on Twitter: @GoAfricaNetwork Diagnostics company Corgenix Medical Corp said on Thursday U.S. health regulators had approved its rapid Ebola test for emergency use, in response to the world’s worst outbreak of the virus that killed more than 10,000 so far. The company’s ReEBOV Antigen Rapid Test, which involves putting a drop of blood
FDA approves Corgenix’s Ebola test for emergency use Read More »
Follow us on Twitter: @GoAfricaNetwork Federal officials said on Thursday that the first clinical trial to test the effectiveness of Ebola vaccines was expected to begin in Liberia in two weeks. Volunteers in the trial will be given either a vaccine being developed by GlaxoSmithKline, a vaccine being developed by Merck or a placebo. There
Trial of 2 Ebola Vaccines’ Effectiveness Is Announced Read More »
Follow us on Twitter: @GoAfricaNetwork Imagine it’s a Sunday in the not-too-distant future. An elderly woman named Sylvia is confined to bed and in pain after breaking two ribs in a fall. She is being tended by a helper robot; let’s call it Fabulon. Sylvia calls out to Fabulon asking for a dose of painkiller.
Follow us on Twitter: @GoAfricaNetwork An unusual method for producing antibiotics may help solve an urgent global problem: the rise in infections that resist treatment with commonly used drugs, and the lack of new antibiotics to replace ones that no longer work. The method, which extracts drugs from bacteria that live in dirt, has yielded a
From a Pile of Dirt, Hope for a Powerful New Antibiotic Read More »
Follow us on Twitter: @GoAfricaNetwork PORT-AU-PRINCE, Haiti — The pictures of medical dysfunction were devastating — broken hospitals in Africa struggling, and largely failing, to contain the Ebola epidemic. As deaths mounted, the problems seemed intractable: no money, no infrastructure, no hope. But across the ocean, Haiti — a broken country if there ever was
In Haiti, Battling Disease With Open-Air Clinics Read More »
Follow us on Twitter: @GoAfricaNetwork A new method for making chemicals that lure tsetse flies to traps has been developed. It uses a cheap by-product from the cashew nut industry as its starting material, so the discovery may mean the flies – which carry sleeping sickness (also known as African trypanosomiasis) – can be trapped
Africa: Cashew Nut By-Product May Help Cut Sleeping Sickness Read More »
